# Heparin Sodium in Sodium Chloride

NDC: 0264-3301
Generic name: Heparin Sodium in Sodium Chloride
Labeler / Manufacturer: B. Braun Medical Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION
Routes: INTRAVENOUS
Marketing started: 20250718

FDA application: NDA019953

## Active ingredients

- HEPARIN SODIUM: 5000 [USP'U]/100mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0264-3301"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0264-3301
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8b030692-fc66-4c53-85aa-6f865e635618